1st Quarter - Amendment

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Firm
Client
Income
—
Expenses
$760,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 20, 2016 $760,000 Replaced
1st Quarter - Amendment (this page) Apr 28, 2016 $760,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
OKEYSHA BROOKS-COLEY —
LAUREN COATOAM —
GREGG HAIFLEY —
BRYAN HANNON —
GRETA JOHNSON —
KATRINA KAMM —
RACHEL MARCUS New Previously employed by Sen. Blanche L. Lincoln (D-AR)
SHERRY MCCAMMON —
MAGGIE OSBORNE —
MATTHEW PHELAN —
CAROLINE POWERS —
DAVID PUGACH —
EMILY WHITE New —
BLAKE WINDHAM —
RICHARD WOODRUFF —

Contacted: SENATE; State, Dept of (DOS); Centers For Disease Control & Prevention (CDC); White House Office; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); U.S. Agency for International Development (USAID); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 1014 (114th), H.R. 2739 (114th), S. 705 (114th), H.R. 716 (114th), S. 1566 (114th), H.R. 644 (114th), H.R. 1608 (114th), S. 540 (114th), H.R. 3119 (114th), H.R. 2191 (114th), S. 370 (114th), S. 1170 (114th), H.R. 2846 (114th)

Medicare/Medicaid MMM

Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
DANA BACON —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
BRYAN HANNON —
KATRINA KAMM —
RACHEL MARCUS New Previously employed by Sen. Blanche L. Lincoln (D-AR)
SHERRY MCCAMMON —
MATTHEW PHELAN —
CAROLINE POWERS —
EMILY WHITE New —
BLAKE WINDHAM —
RICHARD WOODRUFF —

Contacted: White House Office; Food & Drug Administration (FDA); SENATE; Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); U.S. Trade Representative (USTR); Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 1190 (114th), H.R. 1220 (114th), S. 624 (114th)

Budget/Appropriations BUD

Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; and programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H. Con. Res. 25, the FY17 budget resolution, H.R.__, the FY17 Agriculture Appropriations legislation and issues relating to NIH funding in the context of the Senate HELP Committee Medical Innovation legislation.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
DANA BACON —
OKEYSHA BROOKS-COLEY —
LAUREN COATOAM —
GREGG HAIFLEY —
BRYAN HANNON —
GRETA JOHNSON —
KATRINA KAMM —
RACHEL MARCUS New Previously employed by Sen. Blanche L. Lincoln (D-AR)
SHERRY MCCAMMON —
MAGGIE OSBORNE —
MATTHEW PHELAN —
CAROLINE POWERS —
DAVID PUGACH —
EMILY WHITE New —
BLAKE WINDHAM —
RICHARD WOODRUFF —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Labor, Dept of (DOL); Natl Institutes of Health (NIH); U.S. Agency for International Development (USAID); State, Dept of (DOS); Environmental Protection Agency (EPA); White House Office; HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.Con.Res. 25 (114th)

Tobacco TOB

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in H.R.__, FY17 Agriculture Appropriations legislation.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
DANA BACON —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
GRETA JOHNSON —
KATRINA KAMM —
RACHEL MARCUS New Previously employed by Sen. Blanche L. Lincoln (D-AR)
SHERRY MCCAMMON —
MATTHEW PHELAN —
CAROLINE POWERS —
DAVID PUGACH —
RICHARD WOODRUFF —

Contacted: Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); SENATE; Food & Drug Administration (FDA); White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); U.S. Agency for International Development (USAID); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); State, Dept of (DOS); U.S. Trade Representative (USTR)

Bills named: S. 450 (114th), S. 1129 (114th), S. 430 (114th), H.R. 1749 (114th), H.R. 3042 (114th), H.R. 478 (114th)

Taxation/Internal Revenue Code TAX

Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
GREGG HAIFLEY —
RACHEL MARCUS New Previously employed by Sen. Blanche L. Lincoln (D-AR)
CAROLINE POWERS —
RICHARD WOODRUFF —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); State, Dept of (DOS); SENATE; Health & Human Services, Dept of (HHS); U.S. Agency for International Development (USAID); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); Labor, Dept of (DOL); Food & Drug Administration (FDA); White House Office; Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.